3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Basal Cell
4
Chalazion
2
Bone Neoplasms
2
Recurrence
1
Pilonidal Sinus
1
Pain
1
Keratosis, Actinic
1
Giant Cell Tumors
1
Giant Cell Tumor of Bone
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Chondrosarcoma
1
Chondroma
1
Carcinoma, Squamous Cell
1
Bone Cysts
1
Interventions
Filgrastim
4
Proton Therapy
3
Docetaxel
3
regorafenib
2
Sunitinib
2
Ifosfamide
2
Gemcitabine
2
Carboplatin
2
temsirolimus
1
pegfilgrastim
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
ivosidenib
1
itacitinib
1
etoposide phosphate
1
capivasertib
1
baricitinib
1
apatinib
1
angiotensin I (1-7)
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Trabectedin
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Taxes
1
TQ-B3525
1
Surveys and Questionnaires
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chondrosarcoma
×
Curettage
×
Clear all
NCT02996747
2016-12-22
CONDRO1
Istituto Ortopedico Rizzoli
Completed
102 enrolled